MULTIPLE ENDOCRINE NEOPLASIA TYPE 1

Clinical trials for MULTIPLE ENDOCRINE NEOPLASIA TYPE 1 explained in plain language.

Never miss a new study

Get alerted when new MULTIPLE ENDOCRINE NEOPLASIA TYPE 1 trials appear

Sign up with your email to follow new studies for MULTIPLE ENDOCRINE NEOPLASIA TYPE 1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1

New drug combo tested to halt rare, spreading tumors

Disease control Ongoing

This study is testing whether two oral medications, lenvatinib and everolimus, can help control advanced carcinoid tumors that have spread and cannot be surgically removed. The trial aims to see if the drug combination can shrink tumors or stop their growth, and to monitor side e…

Matched conditions: MULTIPLE ENDOCRINE NEOPLASIA TYPE 1

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

MULTIPLE ENDOCRINE NEOPLASIA TYPE 1

Get alerted when new MULTIPLE ENDOCRINE NEOPLASIA TYPE 1 trials appear

New drug combo tested to halt rare, spreading tumors